000 | 01156 a2200313 4500 | ||
---|---|---|---|
005 | 20250514231239.0 | ||
264 | 0 | _c20051110 | |
008 | 200511s 0 0 eng d | ||
022 | _a0263-6352 | ||
024 | 7 |
_a10.1097/01.hjh.0000173511.30116.89 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrain, Nick | |
245 | 0 | 0 |
_aPharmacogenomics in hypertension: present practicalities and future potential. _h[electronic resource] |
260 |
_bJournal of hypertension _cJul 2005 |
||
300 |
_a1327-9 p. _bdigital |
||
500 | _aPublication Type: Comment; Editorial | ||
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aDiuretics _xtherapeutic use |
650 | 0 | 4 | _aHaplotypes |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 | _aPharmacogenetics |
650 | 0 | 4 | _aPolymorphism, Genetic |
700 | 1 | _aDominiczak, Anna F | |
773 | 0 |
_tJournal of hypertension _gvol. 23 _gno. 7 _gp. 1327-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.hjh.0000173511.30116.89 _zAvailable from publisher's website |
999 |
_c15602438 _d15602438 |